Articles
Articles
Meth, J.L. and Schoenfeld, A.R. (2019). Higher percentage of horse serum in culture media blocks attachment of PC12 cells. BioTechniques 67: 00-00 (December 2019)
Shmueli, M.D., Levy-Kanfo, L., Haj, E, Schoenfeld, A.R., Gazit, E., Segal, D. (2018). Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome. Oncogene, Sep 7. doi:. [Epub ahead of print]
Doonachar, A., Gallo, M.D., Doukas, D., Pasricha, R., Lantsberg, I., and Schoenfeld, A. (2015). . Cancer Cell Int., 15:23.
Doonachar, A. and Schoenfeld, A.R. (2014). . CellBio, 3(1), 1-13.
Chiatar, S.S., Eze, O.P., and Schoenfeld, A.R. (2013), . Cell Dev Biol, 2:118.
Bangiyeva, V., Rosenbloom, A., Alexander, A.E., Isanova, B., Popko, T., and Schoenfeld, A.R. (2009). . BMC Cancer, 2009, 9:229.
Hughes, M.D., Kapllani, E., Alexander, A.E., Burk, R.D., and Schoenfeld, A.R. (2007). . Cancer Cell Int., 7:13.
Tannenbaum B., Mofunanya T., and Schoenfeld A.R. (2007). . Int. J. Biol. Sci., 3, 402-407.
for more, see "Other Work" field.
Conference Presentations
Conference Presentations
Pitti, O., Qosaj, F., Michalik, A., Choi, S.-g., Petrov, V., and Schoenfeld, A. (2014). Contribution of atypical PKC toward VHL-associated differentiation of kidney cells. In Mechanisms and Models of Cancer. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
Michalik, A., Abraham, S., Choi, S.-g., Petrov, V., and Schoenfeld, A (2012). Effects of atypical PKC on pVHL-mediated cellular phenotypes. In Meeting on Mechanisms and Models of Cancer. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
Deshpande, P. and Schoenfeld A.R (2010). Effects of lower VHL levels on PC12 pheochromocytoma cells. In Metropolitan Association of College and University Biologists Annual Conference. Molloy College, Rockville Centre, NY.
Gallo, M.D. and Schoenfeld, A.R. (2009). The Effect of VHL on Apoptosis in Renal Cells. In Metropolitan Association of College and University Biologists Annual Conference. Kingsborough Community College, Brooklyn, NY.
Alexander, A., Bangiyeva, V., Popko, T., Rosenbloom, A., and Schoenfeld, A.R. (2008). VHL-mediated morphological changes are independent of HIF-alpha regulation. In Meeting on Mechanisms and Models of Cancer. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
Kapllani, E., Hughes, M.D., Burk, R.D., and Schoenfeld, A.R. (2006). Cellular Roles for VHL gene products that are independent of HIF-alpha regulation. In Meeting on Molecular Models of Cancer. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY.
Invited Presentations
Invited Presentations
A. Schoenfeld (2016, February). Is the Cure for Cancer in Our Reach?, Science Café series, Oceanside Public Library
A. Schoenfeld (2013, October). Intersection of Cellular Phenotypic Effects between Atypical Protein Kinase C and von Hippel-Lindau (VHL) tumor suppressor gene products. St. John's University, Queens, NY.
A. Schoenfeld (2012, November). Cancer: New Cures in a Modern World. Nassau Community College, Garden City, NY.
A. Schoenfeld (2010, October). Cellular insights into von Hippel-Lindau tumor suppressor gene function. Nassau Community College, Garden City, NY.
A. Schoenfeld (2009, February). Cancer: the search for new and improved treatments. Saturday Science Seminar Series, Â鶹ֱ²¥.
A. Schoenfeld (2008, April). Cancer: Looking for Cures. Saturday Science Seminar Series, Â鶹ֱ²¥.
A. Schoenfeld (2007, December). Cellular insights into von Hippel-Lindau tumor suppressor gene function. Â鶹ֱ²¥ Interdisciplinary Seminar.
A. Schoenfeld (2007, May). Cancer: Why haven’t they found a cure. Nassau Science Explorations, at Nassau Community College, Garden City, NY.
Other Work
Other Work
Full publication list:
Meth, J.L. and Schoenfeld, A.R. (2019). Higher percentage of horse serum in culture media blocks attachment of PC12 cells. BioTechniques 67: 00-00 (December 2019)
Shmueli, M.D., Levy-Kanfo, L., Haj, E, Schoenfeld, A.R., Gazit, E., Segal, D. (2018). Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome. Oncogene, Sep 7. doi:. [Epub ahead of print]
Doonachar, A., Gallo, M.D., Doukas, D., Pasricha, R., Lantsberg, I., and Schoenfeld, A. (2015). . Cancer Cell Int., 15:23.
Doonachar, A. and Schoenfeld, A.R. (2014). . CellBio, 3(1), 1-13.
Chiatar, S.S., Eze, O.P., and Schoenfeld, A.R. (2013). . Cell Dev Biol, 2:118.
Bangiyeva, V., Rosenbloom, A., Alexander, A.E., Isanova, B., Popko, T., and Schoenfeld, A.R. (2009). Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes. BMC Cancer 2009, 9(1):229.
Tannenbaum B., Mofunanya T., Schoenfeld A.R. (2007). DNA damage repair is unaffected by mimicked heterozygous levels of BRCA2 in HT-29 cells. Int. J. Biol. Sci. 3, 402-407.
Hughes, M.D., Kapllani, E., Alexander, A.E., Burk, R.D., and Schoenfeld, A.R. (2007). HIF-2alpha downregulation in the absence of functional VHL is not sufficient for renal cell differentiation. Cancer Cell Int. 7:13.
Schoenfeld, A.R., Apgar, S., Dolios, G., Wang, R., and Aaronson, S.A. (2004). BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol. Cell. Biol. 24, 7444-7455.
Schoenfeld, A.R., Davidowitz, E.J., and Burk, R.D. (2001). Endoplasmic reticulum/cytosolic localization of von Hippel-Lindau (VHL) gene products is mediated by a 64 amino acid region. Int. J. Cancer 91, 457-467.
Devarajan, P., DeLeon, M., Talasazan, F., Schoenfeld, A.R., Davidowitz, E.J., and Burk, R.D. (2001). The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways. J. Biol. Chem. 276, 40599-40605.
Davidowitz, E.J., Schoenfeld, A.R., and Burk, R.D. (2001). VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. Mol. Cell. Biol. 21, 865-874.
Schoenfeld, A.R., Davidowitz, E.J., and Burk, R.D. (2000). Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc. Natl. Acad. Sci. USA 97, 8507-8512.
Schoenfeld, A.R., Parris T., Eisenberger A., Davidowitz E.J., De Leon M., Talasazan F., Devarajan P., and Burk, R.D. (2000). The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis. Oncogene 19, 5851-5857.
Schoenfeld, A., Davidowitz, E.J., and Burk, R.D (1998). A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc. Natl. Acad. Sci. USA 95, 8817-8822.
Bai, S., Schoenfeld, A., Pietrangelo , A., and Burk, R.D. (1995). Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein. Mol. Cell. Biol. 15, 1439-1445.
Links provided to external websites, including personal faculty sites, do not imply an endorsement by Â鶹ֱ²¥ of those sites, their content, or associated products and services.